Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.01% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
PTHS · Jun 30, 2026
Pelthos Therapeutics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001919246-26-000113General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-49.12% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
137.61% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
76.86% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-111.02% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.85% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
17.69% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History4 statesHistory building
Period transition
What moved in the state?
- Previous
- 1.78%
- Current
- 0.01%
- Delta
- -1.77%
- Previous
- -120.36%
- Current
- -49.12%
- Delta
- 71.24%
- Previous
- 214.73%
- Current
- 137.61%
- Delta
- -77.11%
- Previous
- 84.66%
- Current
- 76.86%
- Delta
- -7.80%
- Previous
- -120.01%
- Current
- -111.02%
- Delta
- 8.98%
- Previous
- 1.71%
- Current
- 3.85%
- Delta
- 2.14%
- Previous
- 17.49%
- Current
- 17.69%
- Delta
- 0.19%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Biological Products, (No Diagnostic Substances) peers →Derived From · PTHS Company Quality Vector →Has State · Pelthos Therapeutics Inc. →Transitioned To · PTHS Fundamental State →Transitioned To · PTHS CAPEX_INTENSITY_DECREASED →Transitioned To · PTHS CASH_GENERATION_INCREASED →Transitioned To · PTHS INVENTORY_PRESSURE_DECREASED →Transitioned To · PTHS MARGIN_DECREASED →Transitioned To · PTHS PROFITABILITY_INCREASED →Transitioned To · PTHS R_AND_D_INTENSITY_INCREASED →Transitioned To · PTHS SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.